SCHEMBL3694352

SCHEMBL3694352

CC(C)(C)OC(=O)O.CC/C=C\C/C=C\C/C=C\CCCCCCC(CC)CO

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 7/20 0.46
CYP19A1 P11511 4/20 0.46
MAPT P10636 4/20 0.46
F7 P08709 3/20 0.46
F3 P13726 3/20 0.46
OXER1 Q8TDS5 3/20 0.46
PPARG P37231 3/20 0.46
CYP3A4 P08684 2/20 0.46
ALOX15 P16050 2/20 0.46
HSD17B10 Q99714 2/20 0.46
TDP1 Q9NUW8 2/20 0.46
PTGS1 P23219 2/20 0.46
KMT2A Q03164 2/20 0.46
PPARD Q03181 2/20 0.46
PPARA Q07869 2/20 0.46
NR1I2 O75469 2/20 0.46
PTGS2 P35354 2/20 0.46
FFAR1 O14842 2/20 0.46
HPGD P15428 2/20 0.46
KDM4E B2RXH2 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3687558 0.90 ALDH1A1 (0.41) ALDH1A1CYP19A1MAPTF7F3
SCHEMBL3690813 0.84 ALDH1A1 (0.49) ALDH1A1CYP19A1MAPTF7F3
SCHEMBL3692937 0.84 ALDH1A1 (0.49) ALDH1A1CYP19A1MAPTF7F3
SCHEMBL3694353 0.83 ALDH1A1 (0.45) ALDH1A1CYP19A1MAPTF7F3
SCHEMBL3690625 0.83 ALDH1A1 (0.48) ALDH1A1CYP19A1MAPTF7F3
SCHEMBL3695674 0.82 ALDH1A1 (0.36) ALDH1A1CYP19A1MAPTF7F3
SCHEMBL3688789 0.75 ALDH1A1 (0.47) ALDH1A1CYP19A1MAPTF7F3
SCHEMBL7625796 0.75 KDM4E (0.62) ALDH1A1CYP19A1MAPTF7F3
SCHEMBL7620581 0.75 KDM4E (0.62) ALDH1A1CYP19A1MAPTF7F3
SCHEMBL7621800 0.75 KDM4E (0.62) ALDH1A1CYP19A1MAPTF7F3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100240616-A1 NOVEL LIPID COMPOUNDS PRONOVA BIOPHARMA NORGE AS (NO) 2010-09-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100240616-A1 NOVEL LIPID COMPOUNDS ELOVL3, FFAR3, STARD3 ALDH1A1 2317/4885CYP19A1 1573/4885MAPT 4730/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.